Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT01577446Not ApplicableCompleted

Narrow QRS Ischemic Patients Treated With Cardiac Resynchronization Therapy (NARROW CRT)

Role: lead

NCT01647490Not ApplicableUnknown

Right Ventricular Lead Placement in a Pacemaker Population: Evaluation of Apical and Alternative Position

Role: lead

NCT00828360Unknown

Dobutamine Stress Echocardiography in Cardiac Resynchronization Therapy (CRT) Patients Selection

Role: lead

All 3 trials loaded